413 related articles for article (PubMed ID: 16541725)
1. [Progress and perspectives in the treatment of systemic lupus erythematosus].
Robak E; Sysa-Jedrzejowska A; Wozniacka A
Przegl Lek; 2005; 62(9):894-9. PubMed ID: 16541725
[TBL] [Abstract][Full Text] [Related]
2. Recognition and management of systemic lupus erythematosus.
Schroeder JO; Euler HH
Drugs; 1997 Sep; 54(3):422-34. PubMed ID: 9279504
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for juvenile-onset systemic lupus erythematosus.
Carreño L; López-Longo FJ; González CM; Monteagudo I
Paediatr Drugs; 2002; 4(4):241-56. PubMed ID: 11960513
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
Ruiz-Irastorza G; Danza A; Khamashta M
Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
[TBL] [Abstract][Full Text] [Related]
5. Newer drugs for the treatment of lupus nephritis.
Kuiper-Geertsma DG; Derksen RH
Drugs; 2003; 63(2):167-80. PubMed ID: 12515564
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacotherapy of SLE].
Nakazawa T; Kumagai S; Kogata Y
Nihon Rinsho; 2005 May; 63 Suppl 5():253-9. PubMed ID: 15954358
[No Abstract] [Full Text] [Related]
7. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.
Yap DYH; Chan TM
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835612
[TBL] [Abstract][Full Text] [Related]
8. Pragmatic approaches to therapy for systemic lupus erythematosus.
Xiong W; Lahita RG
Nat Rev Rheumatol; 2014 Feb; 10(2):97-107. PubMed ID: 24166241
[TBL] [Abstract][Full Text] [Related]
9. Current status of lupus nephritis.
Jaryal A; Vikrant S
Indian J Med Res; 2017 Feb; 145(2):167-178. PubMed ID: 28639592
[TBL] [Abstract][Full Text] [Related]
10. Novel and emerging drugs for systemic lupus erythematosus: mechanism of action and therapeutic activity.
Robak E; Robak T
Curr Med Chem; 2012; 19(3):438-53. PubMed ID: 22335517
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents.
Karim MY; Alba P; Cuadrado MJ; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
Rheumatology (Oxford); 2002 Aug; 41(8):876-82. PubMed ID: 12154204
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
Pisoni CN; Karim Y; Cuadrado MJ
Lupus; 2005; 14 Suppl 1():s9-11. PubMed ID: 15803925
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of refractory thrombocytopenia with mycophenolate mofetil in a patient with systemic lupus erythematosus.
Chang HK
J Korean Med Sci; 2005 Oct; 20(5):883-5. PubMed ID: 16224167
[TBL] [Abstract][Full Text] [Related]
14. Treatment of severe lupus nephritis: the new horizon.
Chan TM
Nat Rev Nephrol; 2015 Jan; 11(1):46-61. PubMed ID: 25421826
[TBL] [Abstract][Full Text] [Related]
15. [Mycophenolate mofetil--a new therapeutic agent for chronic autoimmune diseases].
Harboe E; Gøransson L; Wildhagen K; Omdal R
Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1650-2. PubMed ID: 15976831
[TBL] [Abstract][Full Text] [Related]
16. Current and emerging lupus treatments.
Wallace D
Am J Manag Care; 2001 Oct; 7(16 Suppl):S490-5. PubMed ID: 11680781
[TBL] [Abstract][Full Text] [Related]
17. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
[TBL] [Abstract][Full Text] [Related]
18. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.
Yahya F; Jasmin R; Ng CT; Cheah TE; Sockalingam S
Int J Rheum Dis; 2013 Dec; 16(6):724-30. PubMed ID: 24119227
[TBL] [Abstract][Full Text] [Related]
19. New treatment strategies for proliferative lupus nephritis: keep children in mind!
Ranchin B; Fargue S
Lupus; 2007; 16(8):684-91. PubMed ID: 17711908
[TBL] [Abstract][Full Text] [Related]
20. Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.
de Luca Montes RA; Huq M; Godfrey T; Oon S; Calderone A; Kandane-Rathnayake R; Louthrenoo W; Luo SF; Jan Wu YJ; Golder V; Lateef A; Navarra SV; Zamora L; Hamijoyo L; Sockalingam S; An Y; Li Z; Katsumata Y; Harigai M; Chan M; Goldblatt F; O'Neill S; Lau CS; Cho J; Hoi A; Karyekar CS; Morand EF; Nikpour M
Adv Rheumatol; 2024 May; 64(1):38. PubMed ID: 38720354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
